Bionano Genomics IncBNGO
▲ PositiveTechnologyrelevance
Appointment of a key scientist with deep OGM expertise to lead R&D and clinical applications.
Impact on stocks 1
Biotech & Genomic Medicine
Bionano Genomics IncBionano Genomics has appointed Alex Hastie as its Chief Scientific Officer, effective July 20, 2026. Dr. Hastie, who spent over 14 years helping develop the company's optical genome mapping technology, returns to lead global scientific strategy and clinical applications development. His appointment drew praise from researchers at Radboud University Medical Center, Johns Hopkins, MD Anderson, and Dartmouth Hitchcock, who highlighted his deep expertise in OGM. Bionano said Dr. Hastie will focus on strengthening clinical and research collaborations and accelerating the translation of OGM into broader research use.
Bionano Genomics IncAppointment of a key scientist with deep OGM expertise to lead R&D and clinical applications.